EVOLUTION FPO achieves record production: What you need to know

EVOLUTION FPO (ASX:EVN) produced a record amount of gold during the 2015 financial year.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of EVOLUTION FPO (ASX: EVN) have slipped another 2.9% today after the Australian gold producer announced its fourth quarter production results.

For the three months ended 30 June 2015, Evolution recorded a record quarterly production of 113,821 ounces of gold which represents a 10.2% increase on the 103,305 ounces produced in the three months immediately prior. It achieved this result at an all-in sustaining cost (AISC) of US$816 an ounce (A$1,048).

The strong performance topped off a record year for the group which produced a total 437,570 gold equivalent ounces (compared to guidance of 400,000 to 440,000 ounces) – an increase of 2.3% compared to the 2014 financial year – at an AISC of US$807 an ounce (A$1,036). The result was largely bolstered by a better-than-expected performance from its Edna May mine in Western Australia which exceeded production expectations and recorded below guidance costs.

The miner also benefited from its continued focus on cost-cutting initiatives and a lower Australian dollar which helped to offset the impact of lower gold prices around the world.

Indeed, gold experienced a flash crash during yesterday's session and hit a new five-year low beneath US$1,100 an ounce. Evolution's shares fell almost 15% while Newcrest Mining Limited (ASX: NCM) and Northern Star Resources Ltd (ASX: NST) dropped 10.1% and 9.6%, respectively.

In regards to 2016, Evolution said that it intends to provide a detailed outlook in August following the completion of the Mungari and Cowal acquisitions that were announced earlier this year. With gold prices falling however, investors might be wise to give Evolution a miss, for now.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »